Safe-T: Private Investment of NIS 22.5M supports positive momentum that is in line with company’s strategy. Target price raised to NIS 9.38 jaimeuss_admin 17 בSeptember 2018 Research 0 Comments Continue Reading
RedHill Biopharma Ltd.: The acceleration of RHB-104 Phase III Study in Crohn’s disease increases company value and share price. jaimeuss_admin 17 בSeptember 2018 Research 0 Comments Continue Reading
DNA Biomedical Solutions Ltd.: The company and its holdings can become a major force in the osteoporosis care market, pending success in next year’s clinical trials. jaimeuss_admin 6 בSeptember 2018 Research 0 Comments Continue Reading
Vonetize Plc: Investment Opportunity in VOD for Emerging Countries and Israel; Agreement with Triple C is Expected to Significantly Increase Vonetize Revenues jaimeuss_admin 30 בAugust 2018 Research 0 Comments Continue Reading
Safe-T: Private Investment of NIS 22.5M supports positive momentum that is in line with company’s strategy. Target price raised to NIS 9.38 jaimeuss_admin 30 בAugust 2018 Research 0 Comments Continue Reading